{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:38:35Z","timestamp":1792787915332,"version":"4.5.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":7,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the National High Level Hospital Clinical Research Funding Project","award":["BJ-2024-187"],"award-info":[{"award-number":["BJ-2024-187"]}]},{"name":"the National High Level Hospital Clinical Research Funding Project","award":["BJ-2024-093"],"award-info":[{"award-number":["BJ-2024-093"]}]},{"name":"the National High Level Hospital Clinical Research Funding Project","award":["BJ-2024-142"],"award-info":[{"award-number":["BJ-2024-142"]}]},{"name":"the National Natural Science Foundation of China","award":["82470514"],"award-info":[{"award-number":["82470514"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the Basic Scientific Research Funds for Central Public Welfare Research Institutes, Chinese Academy of Medical Sciences","award":["2025-JKCS-24"],"award-info":[{"award-number":["2025-JKCS-24"]}],"id":[{"id":"https:\/\/ror.org\/02drdmm93","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the CAMS Innovation Engineering Project","award":["2025-I2M-TS-18"],"award-info":[{"award-number":["2025-I2M-TS-18"]}]},{"name":"the Beijing Natural Science Foundation","award":["L256072"],"award-info":[{"award-number":["L256072"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-026-06621-y","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T01:36:59Z","timestamp":1789609019000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Residual lipid-related proteomic and metabolomic signatures associated with major adverse cardiovascular events after revascularization in peripheral artery disease"],"prefix":"10.1186","volume":"26","author":[{"given":"Shaobo","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0097-6543","authenticated-orcid":false,"given":"Bowen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuping","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengran","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenguang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuoguan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongpeng","family":"Diao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,17]]},"reference":[{"issue":"43","key":"6621_CR1","doi-asserted-by":"publisher","first-page":"4528","DOI":"10.1093\/eurheartj\/ehac448","volume":"43","author":"X Zhou","year":"2022","unstructured":"Zhou X, Yu L, Zhao Y, Ge J. Panvascular medicine: an emerging discipline focusing on atherosclerotic diseases. Eur Heart J. 2022;43(43):4528\u201331.","journal-title":"Eur Heart J"},{"issue":"5","key":"6621_CR2","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1056\/NEJMcp2501200","volume":"394","author":"MM McDermott","year":"2026","unstructured":"McDermott MM. Peripheral Artery Disease in the Legs. N Engl J Med. 2026;394(5):486\u201396.","journal-title":"N Engl J Med"},{"issue":"21","key":"6621_CR3","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1001\/jama.2021.2126","volume":"325","author":"TS Polonsky","year":"2021","unstructured":"Polonsky TS, McDermott MM. Lower Extremity Peripheral Artery Disease Without Chronic Limb-Threatening Ischemia: A Review. JAMA. 2021;325(21):2188\u201398.","journal-title":"JAMA"},{"key":"6621_CR4","doi-asserted-by":"publisher","first-page":"8295054","DOI":"10.1155\/2019\/8295054","volume":"2019","author":"R Bauersachs","year":"2019","unstructured":"Bauersachs R, Zeymer U, Bri\u00e8re JB, Marre C, Bowrin K, Huelsebeck M. Burden of Coronary Artery Disease and Peripheral Artery Disease: A Literature Review. Cardiovasc Ther. 2019;2019:8295054.","journal-title":"Cardiovasc Ther"},{"issue":"1","key":"6621_CR5","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s41572-025-00651-0","volume":"11","author":"V Aboyans","year":"2025","unstructured":"Aboyans V, Canonico ME, Chastaingt L, Anand SS, Brodmann M, Couffinhal T, et al. Peripheral artery disease. Nat Rev Dis Primers. 2025;11(1):68.","journal-title":"Nat Rev Dis Primers"},{"issue":"9","key":"6621_CR6","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1161\/CIRCULATIONAHA.124.073579","volume":"152","author":"TR Bellomo","year":"2025","unstructured":"Bellomo TR, Bramel EE, Lee J, Urbut S, Flores A, Yu Z, et al. Evaluation of Lipoprotein(a) as a Prognostic Marker of Extracoronary Atherosclerotic Vascular Disease Progression. Circulation. 2025;152(9):585\u201398.","journal-title":"Circulation"},{"issue":"12","key":"6621_CR7","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1016\/j.jacc.2024.12.033","volume":"85","author":"BN Wadstr\u00f6m","year":"2025","unstructured":"Wadstr\u00f6m BN, Borges MC, Wulff AB, Smith GD, Sanderson E, Nordestgaard BG. Elevated Remnant and LDL Cholesterol and the Risk of Peripheral Artery Disease: A Mendelian Randomization Study. J Am Coll Cardiol. 2025;85(12):1353\u201368.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"6621_CR8","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1161\/CIRCULATIONAHA.121.053797","volume":"144","author":"MG Levin","year":"2021","unstructured":"Levin MG, Zuber V, Walker VM, Klarin D, Lynch J, Malik R, et al. Prioritizing the Role of Major Lipoproteins and Subfractions as Risk Factors for Peripheral Artery Disease. Circulation. 2021;144(5):353\u201364.","journal-title":"Circulation"},{"issue":"17","key":"6621_CR9","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1016\/j.jacc.2020.02.059","volume":"75","author":"EK Duran","year":"2020","unstructured":"Duran EK, Aday AW, Cook NR, Buring JE, Ridker PM, Pradhan AD. Triglyceride-Rich Lipoprotein Cholesterol, Small Dense LDL Cholesterol, and Incident Cardiovascular Disease. J Am Coll Cardiol. 2020;75(17):2122\u201335.","journal-title":"J Am Coll Cardiol"},{"issue":"24","key":"6621_CR10","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1016\/j.jacc.2024.04.003","volume":"83","author":"KJ Bates","year":"2024","unstructured":"Bates KJ, Moore MM, Cibotti-Sun M. 2024 Lower Extremity Peripheral Artery Disease Guideline-at-a-Glance. J Am Coll Cardiol. 2024;83(24):2605\u20139.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"6621_CR11","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1001\/jama.2025.8408","volume":"334","author":"A Kansal","year":"2025","unstructured":"Kansal A, Davis AM, Rymer JA. Management of Peripheral Artery Disease. JAMA. 2025;334(5):444\u20135.","journal-title":"JAMA"},{"issue":"25","key":"6621_CR12","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.1016\/j.jacc.2024.04.034","volume":"83","author":"CN Hess","year":"2024","unstructured":"Hess CN, Daffron A, Nehler MR, Morrison JT, Buchanan CE, Szarek M, et al. Randomized Trial of a Vascular Care Team vs Education for Patients With Peripheral Artery Disease. J Am Coll Cardiol. 2024;83(25):2658\u201370.","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"6621_CR13","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1161\/CIRCULATIONAHA.120.047994","volume":"143","author":"M S\u00f8gaard","year":"2021","unstructured":"S\u00f8gaard M, Nielsen PB, Skj\u00f8th F, Eldrup N, Larsen TB. Temporal Changes in Secondary Prevention and Cardiovascular Outcomes After Revascularization for Peripheral Arterial Disease in Denmark: A Nationwide Cohort Study. Circulation. 2021;143(9):907\u201320.","journal-title":"Circulation"},{"issue":"36","key":"6621_CR14","doi-asserted-by":"publisher","first-page":"3538","DOI":"10.1093\/eurheartj\/ehae179","volume":"45","author":"L Mazzolai","year":"2024","unstructured":"Mazzolai L, Teixido-Tura G, Lanzi S, Boc V, Bossone E, Brodmann M, et al. 2024 ESC Guidelines for the management of peripheral arterial and aortic diseases. Eur Heart J. 2024;45(36):3538\u2013700.","journal-title":"Eur Heart J"},{"issue":"24","key":"6621_CR15","doi-asserted-by":"publisher","first-page":"e1313","DOI":"10.1161\/CIR.0000000000001251","volume":"149","author":"HL Gornik","year":"2024","unstructured":"Gornik HL, Aronow HD, Goodney PP, Arya S, Brewster LP, Byrd L, et al. 2024 ACC\/AHA\/AACVPR\/APMA\/ABC\/SCAI\/SVM\/SVN\/SVS\/SIR\/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2024;149(24):e1313\u2013410.","journal-title":"Circulation"},{"key":"6621_CR16","doi-asserted-by":"crossref","unstructured":"Nordanstig J, Behrendt CA, Baumgartner I, Belch J, B\u00e4ck M, Fitridge R, et al. editors. \u2018s Choice -- European Society for Vascular Surgery (ESVS) 2024 Clinical Practice Guidelines on the Management of Asymptomatic Lower Limb Peripheral Arterial Disease and Intermittent Claudication. Eur J Vasc Endovasc Surg. 2024;67(1):9\u201396.","DOI":"10.1016\/j.ejvs.2023.08.067"},{"key":"6621_CR17","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.atherosclerosis.2021.09.022","volume":"338","author":"JJF Belch","year":"2021","unstructured":"Belch JJF, Brodmann M, Baumgartner I, Binder CJ, Casula M, Heiss C, et al. Lipid-lowering and anti-thrombotic therapy in patients with peripheral arterial disease: European Atherosclerosis Society\/European Society of Vascular Medicine Joint Statement. Atherosclerosis. 2021;338:55\u201363.","journal-title":"Atherosclerosis"},{"issue":"14","key":"6621_CR18","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1136\/heartjnl-2019-315615","volume":"107","author":"A Iliou","year":"2021","unstructured":"Iliou A, Mikros E, Karaman I, Elliott F, Griffin JL, Tzoulaki I, et al. Metabolic phenotyping and cardiovascular disease: an overview of evidence from epidemiological settings. Heart. 2021;107(14):1123\u20139.","journal-title":"Heart"},{"issue":"18","key":"6621_CR19","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1093\/eurheartj\/ehad161","volume":"44","author":"NS Nurmohamed","year":"2023","unstructured":"Nurmohamed NS, Kraaijenhof JM, Mayr M, Nicholls SJ, Koenig W, Catapano AL, et al. Proteomics and lipidomics in atherosclerotic cardiovascular disease risk prediction. Eur Heart J. 2023;44(18):1594\u2013607.","journal-title":"Eur Heart J"},{"key":"6621_CR20","doi-asserted-by":"crossref","unstructured":"Luo Y, Zhang N, Yang J, Cui M, Tsoi KKF, Lip GYH et al. AI-based multiomics profiling reveals complementary omics contributions to personalized prediction of cardiovascular disease. Nat Commun. 2026;17(1).","DOI":"10.1038\/s41467-026-68956-6"},{"key":"6621_CR21","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9:559.","journal-title":"BMC Bioinformatics"},{"key":"6621_CR22","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1186\/1471-2105-11-367","volume":"11","author":"R Gaujoux","year":"2010","unstructured":"Gaujoux R, Seoighe C. A flexible R package for nonnegative matrix factorization. BMC Bioinformatics. 2010;11:367.","journal-title":"BMC Bioinformatics"},{"issue":"7","key":"6621_CR23","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"6621_CR24","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. Omics. 2012;16(5):284\u20137.","journal-title":"Omics"},{"issue":"Suppl 2","key":"6621_CR25","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12859-015-0854-z","volume":"17","author":"SE Bouhaddani","year":"2016","unstructured":"Bouhaddani SE, Houwing-Duistermaat J, Salo P, Perola M, Jongbloed G, Uh HW. Evaluation of O2PLS in Omics data integration. BMC Bioinformatics. 2016;17(Suppl 2):11.","journal-title":"BMC Bioinformatics"},{"issue":"1","key":"6621_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v033.i01","volume":"33","author":"J Friedman","year":"2010","unstructured":"Friedman J, Hastie T, Tibshirani R. Regularization Paths for Generalized Linear Models via Coordinate Descent. J Stat Softw. 2010;33(1):1\u201322.","journal-title":"J Stat Softw"},{"key":"6621_CR27","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1471-2105-12-77","volume":"12","author":"X Robin","year":"2011","unstructured":"Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez JC, et al. pROC: an open-source package for R and S\u2009+\u2009to analyze and compare ROC curves. BMC Bioinformatics. 2011;12:77.","journal-title":"BMC Bioinformatics"},{"issue":"30","key":"6621_CR28","doi-asserted-by":"publisher","first-page":"5381","DOI":"10.1002\/sim.5958","volume":"32","author":"P Blanche","year":"2013","unstructured":"Blanche P, Dartigues JF, Jacqmin-Gadda H. Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks. Stat Med. 2013;32(30):5381\u201397.","journal-title":"Stat Med"},{"issue":"18","key":"6621_CR29","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","volume":"32","author":"Z Gu","year":"2016","unstructured":"Gu Z, Eils R, Schlesner M. Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics. 2016;32(18):2847\u20139.","journal-title":"Bioinformatics"},{"issue":"W1","key":"6621_CR30","doi-asserted-by":"publisher","first-page":"W486","DOI":"10.1093\/nar\/gky310","volume":"46","author":"J Chong","year":"2018","unstructured":"Chong J, Soufan O, Li C, Caraus I, Li S, Bourque G, et al. MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis. Nucleic Acids Res. 2018;46(W1):W486\u201394.","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"6621_CR31","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1177\/17085381241260203","volume":"33","author":"A Evsen","year":"2025","unstructured":"Evsen A, Aktan A, Altunova M, \u00d6zbek M. Is plasma atherogenic index or LDL\/HDL ratio more predictive of peripheral arterial disease complexity? Vascular. 2025;33(3):648\u201353.","journal-title":"Vascular"},{"issue":"2","key":"6621_CR32","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1177\/17085381231193494","volume":"32","author":"M Altunova","year":"2024","unstructured":"Altunova M, Karakayali M, Yildirim Karakan C, T\u00fckenmez Karakurt S, Demirci G, Aslan S, et al. The relationship between plasma atherogenic index and long-term outcomes after endovascular intervention in superficial femoral artery lesions. Vascular. 2024;32(2):310\u20139.","journal-title":"Vascular"},{"issue":"22","key":"6621_CR33","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1093\/eurheartj\/ehad241","volume":"44","author":"G Liuzzo","year":"2023","unstructured":"Liuzzo G, Patrono C. Targeting residual cardiovascular risk in the statin era: cholesterol or inflammation? Eur Heart J. 2023;44(22):1973\u20135.","journal-title":"Eur Heart J"},{"issue":"16","key":"6621_CR34","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1016\/j.jacc.2024.03.370","volume":"83","author":"MJ Blaha","year":"2024","unstructured":"Blaha MJ, Bhatia HS. Lipoprotein(a), Residual Cardiovascular Risk, and the Search for Targeted Therapy. J Am Coll Cardiol. 2024;83(16):1540\u20132.","journal-title":"J Am Coll Cardiol"},{"issue":"18","key":"6621_CR35","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","volume":"376","author":"MS Sabatine","year":"2017","unstructured":"Sabatine MS, Giugliano RP, Keech AC, Honarpour N, Wiviott SD, Murphy SA, et al. Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease. N Engl J Med. 2017;376(18):1713\u201322.","journal-title":"N Engl J Med"},{"issue":"44","key":"6621_CR36","doi-asserted-by":"publisher","first-page":"4737","DOI":"10.1093\/eurheartj\/ehaf606","volume":"46","author":"CM Ballantyne","year":"2025","unstructured":"Ballantyne CM, Norata GD. The evolving landscape of targets for lipid lowering: from molecular mechanisms to translational implications. Eur Heart J. 2025;46(44):4737\u201350.","journal-title":"Eur Heart J"},{"issue":"1","key":"6621_CR37","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s43556-025-00321-3","volume":"6","author":"D Cui","year":"2025","unstructured":"Cui D, Yu X, Guan Q, Shen Y, Liao J, Liu Y, et al. Cholesterol metabolism: molecular mechanisms, biological functions, diseases, and therapeutic targets. Mol Biomed. 2025;6(1):72.","journal-title":"Mol Biomed"},{"key":"6621_CR38","doi-asserted-by":"crossref","unstructured":"Su S, Wang W, Lin Z, Yang X, Fu Y, Lu X et al. Circulating ceramides and sphingomyelins: key biomarkers and targets in cardiovascular prevention. Sci China Life Sci. 2026.","DOI":"10.1007\/s11427-025-3050-y"},{"issue":"2","key":"6621_CR39","doi-asserted-by":"publisher","first-page":"e044903","DOI":"10.1161\/JAHA.125.044903","volume":"15","author":"T Chen","year":"2026","unstructured":"Chen T, Xie L, Zhao Y, Shang Y, Pan Y, Wang W, et al. Exploring Ceramide C16:0 as a Novel Biomarker and Therapeutic Target for Atherosclerosis. J Am Heart Assoc. 2026;15(2):e044903.","journal-title":"J Am Heart Assoc"},{"issue":"20","key":"6621_CR40","doi-asserted-by":"publisher","first-page":"2494","DOI":"10.1016\/j.jacc.2021.03.314","volume":"77","author":"N Akawi","year":"2021","unstructured":"Akawi N, Checa A, Antonopoulos AS, Akoumianakis I, Daskalaki E, Kotanidis CP, et al. Fat-Secreted Ceramides Regulate Vascular Redox State and Influence Outcomes in Patients With Cardiovascular Disease. J Am Coll Cardiol. 2021;77(20):2494\u2013513.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"6621_CR41","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/s44161-025-00638-w","volume":"4","author":"N Sadhu","year":"2025","unstructured":"Sadhu N, Dalan R, Jain PR, Lee CJM, Pakkiri LS, Tay KY, et al. Metabolome-wide association identifies ferredoxin-1 (FDX1) as a determinant of cholesterol metabolism and cardiovascular risk in Asian populations. Nat Cardiovasc Res. 2025;4(5):567\u201383.","journal-title":"Nat Cardiovasc Res"},{"issue":"6","key":"6621_CR42","doi-asserted-by":"publisher","first-page":"353","DOI":"10.5582\/bst.2021.01320","volume":"15","author":"S Zhang","year":"2022","unstructured":"Zhang S, Zhou J, Li L, Pan X, Lin J, Li C, et al. Effect of dehydroepiandrosterone on atherosclerosis in postmenopausal women. Biosci Trends. 2022;15(6):353\u201364.","journal-title":"Biosci Trends"},{"key":"6621_CR43","doi-asserted-by":"publisher","first-page":"157924","DOI":"10.1016\/j.phymed.2026.157924","volume":"153","author":"Y Gu","year":"2026","unstructured":"Gu Y, Jin Y, Zhao H, Tang J, Li Z, Cheng S, et al. Dingxin recipe \u2162 ameliorates atherosclerosis through stard4-mediated regulation of hepatic lipid metabolism. Phytomedicine. 2026;153:157924.","journal-title":"Phytomedicine"},{"issue":"6","key":"6621_CR44","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1161\/CIRCULATIONAHA.124.069210","volume":"151","author":"A Greco","year":"2025","unstructured":"Greco A, Finocchiaro S, Spagnolo M, Faro DC, Mauro MS, Raffo C, et al. Lipoprotein(a) as a Pharmacological Target: Premises, Promises, and Prospects. Circulation. 2025;151(6):400\u201315.","journal-title":"Circulation"},{"issue":"5","key":"6621_CR45","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1001\/jamacardio.2024.5433","volume":"10","author":"RS Rosenson","year":"2025","unstructured":"Rosenson RS, L\u00f3pez JAG, Gaudet D, Baum SJ, Stout E, Lepor NE, et al. Olpasiran, Oxidized Phospholipids, and Systemic Inflammatory Biomarkers: Results From the OCEAN(a)-DOSE Trial. JAMA Cardiol. 2025;10(5):482\u20136.","journal-title":"JAMA Cardiol"},{"key":"6621_CR46","doi-asserted-by":"publisher","first-page":"1793466","DOI":"10.3389\/fmolb.2026.1793466","volume":"13","author":"J Wang","year":"2026","unstructured":"Wang J, Li H, She Y, Xu C, Peng K, Ding W. Research progress on the damage of lipid peroxidation to the body and its correlation with metabolic diseases. Front Mol Biosci. 2026;13:1793466.","journal-title":"Front Mol Biosci"},{"issue":"1","key":"6621_CR47","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12933-025-02624-9","volume":"24","author":"W Le Goff","year":"2025","unstructured":"Le Goff W, Bourron O, Materne C, Galier S, Phan F, Tan-Chen S, et al. Inverse relationship between circulating sphingosine-1-phosphate and precursor species and coronary artery calcification score in type 2 diabetes. Cardiovasc Diabetol. 2025;24(1):85.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"6621_CR48","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1038\/s41467-025-56869-9","volume":"16","author":"L Rubinelli","year":"2025","unstructured":"Rubinelli L, Manzo OL, Sungho J, Del Gaudio I, Bareja R, Marino A, et al. Suppression of endothelial ceramide de novo biosynthesis by Nogo-B contributes to cardiometabolic diseases. Nat Commun. 2025;16(1):1968.","journal-title":"Nat Commun"},{"issue":"6","key":"6621_CR49","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3892\/br.2022.1536","volume":"16","author":"C Frangie","year":"2022","unstructured":"Frangie C, Daher J. Role of myeloperoxidase in inflammation and atherosclerosis (Review). Biomed Rep. 2022;16(6):53.","journal-title":"Biomed Rep"},{"issue":"1","key":"6621_CR50","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMp058118","volume":"353","author":"JA Berliner","year":"2005","unstructured":"Berliner JA, Watson AD. A role for oxidized phospholipids in atherosclerosis. N Engl J Med. 2005;353(1):9\u201311.","journal-title":"N Engl J Med"},{"issue":"1","key":"6621_CR51","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1055\/s-0038-1646175","volume":"70","author":"I Juhan-Vague","year":"1993","unstructured":"Juhan-Vague I, Alessi MC. Plasminogen activator inhibitor 1 and atherothrombosis. Thromb Haemost. 1993;70(1):138\u201343.","journal-title":"Thromb Haemost"},{"issue":"Suppl 1","key":"6621_CR52","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/j.1538-7836.2007.02516.x","volume":"5","author":"JC Rau","year":"2007","unstructured":"Rau JC, Beaulieu LM, Huntington JA, Church FC. Serpins in thrombosis, hemostasis and fibrinolysis. J Thromb Haemost. 2007;5(Suppl 1):102\u201315.","journal-title":"J Thromb Haemost"},{"issue":"1","key":"6621_CR53","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s11883-025-01364-1","volume":"27","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Han L, Wang Y, Wang M. The Role of the PI3K\/Akt\/mTOR Pathway in Atherosclerosis: Mechanisms, Therapeutic Potential, and Emerging Targeted Treatments. Curr Atheroscler Rep. 2025;27(1):115.","journal-title":"Curr Atheroscler Rep"},{"issue":"6","key":"6621_CR54","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s40265-025-02179-9","volume":"85","author":"M Cazzola","year":"2025","unstructured":"Cazzola M, Page C, Rogliani P, Calzetta L, Matera MG. PI3K Inhibitors as Potential Therapeutic Agents for the Treatment of COPD with Associated Atherosclerosis. Drugs. 2025;85(6):741\u201353.","journal-title":"Drugs"},{"issue":"21","key":"6621_CR55","doi-asserted-by":"publisher","first-page":"4851","DOI":"10.1002\/pmic.200800973","volume":"9","author":"CK Lee","year":"2009","unstructured":"Lee CK, Han JS, Won KJ, Jung SH, Park HJ, Lee HM, et al. Diminished expression of dihydropteridine reductase is a potent biomarker for hypertensive vessels. Proteomics. 2009;9(21):4851\u20138.","journal-title":"Proteomics"},{"issue":"8","key":"6621_CR56","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1093\/abbs\/gmx061","volume":"49","author":"Q Si","year":"2017","unstructured":"Si Q, Sun S, Gu Y. A278C mutation of dihydropteridine reductase decreases autophagy via mTOR signaling. Acta Biochim Biophys Sin (Shanghai). 2017;49(8):706\u201312.","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"issue":"6","key":"6621_CR57","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1161\/01.ATV.0000125114.88079.96","volume":"24","author":"S Kawashima","year":"2004","unstructured":"Kawashima S, Yokoyama M. Dysfunction of endothelial nitric oxide synthase and atherosclerosis. Arterioscler Thromb Vasc Biol. 2004;24(6):998\u20131005.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"6621_CR58","doi-asserted-by":"publisher","first-page":"831039","DOI":"10.3389\/fcvm.2022.831039","volume":"9","author":"AK Kumawat","year":"2022","unstructured":"Kumawat AK, Zegeye MM, Paramel GV, Baumgartner R, Gister\u00e5 A, Amegavie O, et al. Inhibition of IL17A Using an Affibody Molecule Attenuates Inflammation in ApoE-Deficient Mice. Front Cardiovasc Med. 2022;9:831039.","journal-title":"Front Cardiovasc Med"},{"issue":"5","key":"6621_CR59","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/s44161-025-00637-x","volume":"4","author":"Z Qi","year":"2025","unstructured":"Qi Z, Zhang W, Zhang P, Qu Y, Zhong H, Zhou L, et al. The gut microbiota-bile acid-TGR5 axis orchestrates platelet activation and atherothrombosis. Nat Cardiovasc Res. 2025;4(5):584\u2013601.","journal-title":"Nat Cardiovasc Res"},{"issue":"3","key":"6621_CR60","doi-asserted-by":"publisher","first-page":"e70034","DOI":"10.1111\/sms.70034","volume":"35","author":"J Bork","year":"2025","unstructured":"Bork J, Markus MRP, Ewert R, Nauck M, Templin C, V\u00f6lzke H, et al. The Metabolic Signature of Cardiorespiratory Fitness. Scand J Med Sci Sports. 2025;35(3):e70034.","journal-title":"Scand J Med Sci Sports"},{"issue":"1","key":"6621_CR61","first-page":"18","volume":"21","author":"N Zhou","year":"2019","unstructured":"Zhou N, Tang L, Jiang Y, Qin S, Cui J, Wang Y, et al. Whole-exome sequencing reveals a novel mutation of MT-ND5 gene in a mitochondrial cardiomyopathy pedigree: Patients who show biventricular hypertrophy, hyperlactacidemia, pulmonary hypertension, and decreased exercise tolerance. Anatol J Cardiol. 2019;21(1):18\u201324.","journal-title":"Anatol J Cardiol"},{"key":"6621_CR62","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3389\/fendo.2020.00212","volume":"11","author":"S Zhao","year":"2020","unstructured":"Zhao S, Feng XF, Huang T, Luo HH, Chen JX, Zeng J, et al. The Association Between Acylcarnitine Metabolites and Cardiovascular Disease in Chinese Patients With Type 2 Diabetes Mellitus. Front Endocrinol (Lausanne). 2020;11:212.","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-026-06621-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-06621-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-06621-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T14:03:42Z","timestamp":1790258622000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12872-026-06621-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,17]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6621"],"URL":"https:\/\/doi.org\/10.1186\/s12872-026-06621-y","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,17]]},"assertion":[{"value":"3 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics Committee of Beijing Hospital (approval number: 2025BJYYEC-KY171-01). All participants provided written informed consent prior to enrollment. The study was conducted in accordance with the principles of the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"833"}}